GODREJAGRONSEGodrej Agrovet LimitedMinimalNeutral
Announced Fri, 1 May · 12:48 IST

Godrej Agrovet Limited has informed the Exchange about Copy of Newspaper Publication

GODREJAGRO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.8%1-day move
₹600.00
prior close
₹607.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-1.6-2.1-3.6-4.8-3.3-1.8-1.3-2.9-6.2-4.5-4.2-5.3
Up moveDown movePending
AI summary

Godrej Agrovet Limited has published its audited financial results for Q4 and Financial Year ended March 31, 2026. Consolidated total income grew 9.1% to Rs. 10,232.68 Crore for FY26 from Rs. 9,382.77 Crore in FY25. Net profit after tax increased 10.4% to Rs. 445.18 Crore (FY26) from Rs. 403.37 Crore (FY25), with basic EPS of Rs. 24.58. The Board has recommended a final dividend of Rs. 11 per equity share. Notable items include acquisition of additional 36.79% stake in Creamline Dairy Products for Rs. 708.58 Crore (now holding 99.78%), impairment provision of Rs. 32.96 Crore in Godrej Cattle Genetics, and profit of Rs. 33.48 Crore from land sale. The company also participated in Astec LifeSciences rights issue worth Rs. 199.01 Crore.

Likely market impact

Strong financial performance with double-digit profit growth; positive for shareholders with dividend recommendation and strategic acquisitions.